Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2005 Sep;82(3):456–467. doi: 10.1093/jurban/jti091

Challenges in motivating treatment enrollment in community syringe exchange participants

Michael Kidorf 1,✉, Elizabeth Disney 1, Van King 1, Ken Kolodner 1, Peter Beilenson 2, Robert K Brooner 1
PMCID: PMC3456055  PMID: 16014875

Abstract

Participants of syringe exchange programs (SEPs) exhibit high rates of substance use disorder but remain extremely ambivalent about seeking treatment. This study evaluated the effectiveness of motivational interviewing (MI) for encouraging SEP participants to enroll in substance abuse treatment. New opioid-dependent registrants to the Baltimore Needle Exchange Program (BNEP) (n=302) completed the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and the Addiction Severity Index (ASI) and were randomly assigned to one of three treatment referral conditions: (1) MI, (2) job readiness (JR) (attention control), or (3) standard referral. Participants in each condition who expressed interest in treatment were referred to a treatment readiness group that provided further encouragement and referral to programs that were accepting new admissions. Participants were observed for 1 year following the intervention. The results showed that 10.9% of study participants enrolled in substance abuse treatment, although no condition effects were observed. White participants and those diagnosed with major depression were most likely to enter treatment. The results suggest that a single motivational interview is insufficient to motivate changes in treatment seeking in this population, whereas the identification of predictors of treatment enrollment is worthy of further investigation.

Keywords: Major depression, Motivational interviewing, Opioid abuse, Substance abuse treatment, Syringe exchange

Full Text

The Full Text of this article is available as a PDF (104.7 KB).

References

  • 1.Vlahov D, Jarlais DC, Goospby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154:S70–S77. doi: 10.1093/aje/154.12.S70. [DOI] [PubMed] [Google Scholar]
  • 2.Jarlais DC, Friedman SR, Casriel C. Target groups for preventing AIDS among intravenous drug users 2. The “hard” data studies. J Consult Clin Psychol. 1990;58:50–56. doi: 10.1037/0022-006X.58.1.50. [DOI] [PubMed] [Google Scholar]
  • 3.Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 4.Kaplan EH, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr. 1994;7:182–189. [PubMed] [Google Scholar]
  • 5.Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993;95:214–220. doi: 10.1016/0002-9343(93)90263-O. [DOI] [PubMed] [Google Scholar]
  • 6.Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high risk drug use behaviors among participants in the Baltimore needle exchange program. J AIDS Human Retrovirology. 1997;16:400–406. doi: 10.1097/00042560-199712150-00014. [DOI] [PubMed] [Google Scholar]
  • 7.Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51:1771–1782. doi: 10.1016/S0277-9536(00)00109-X. [DOI] [PubMed] [Google Scholar]
  • 8.Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329–1341. doi: 10.1097/00002030-200107270-00002. [DOI] [PubMed] [Google Scholar]
  • 9.Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994–1002. doi: 10.1093/oxfordjournals.aje.a009240. [DOI] [PubMed] [Google Scholar]
  • 10.Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999;76:448–460. doi: 10.1007/BF02351502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kidorf M, Disney ER, King VL, Neufeld KJ, Beilenson PL, Brooner RK. Prevalence of psychiatric and substance use disorders in opioid abusers participating in a needle exchange program. Drug Alcohol Depend. 2004;74:115–222. doi: 10.1016/j.drugalcdep.2003.11.014. [DOI] [PubMed] [Google Scholar]
  • 12.Brooner RK, King VL, Kidorf M, Schmidt CW, Jr., Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71–80. doi: 10.1001/archpsyc.1997.01830130077015. [DOI] [PubMed] [Google Scholar]
  • 13.Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment? J Subst Abuse Treat. 1998;15:183–191. doi: 10.1016/S0740-5472(97)00220-1. [DOI] [PubMed] [Google Scholar]
  • 14.Metzger D, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113:97–106. [PMC free article] [PubMed] [Google Scholar]
  • 15.Brooner RK, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998;113(Suppl. I):129–139. [PMC free article] [PubMed] [Google Scholar]
  • 16.Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in the methadone maintenance treatment programs differ by HIV-serostatus. AIDS. 2000;14:2035–2043. doi: 10.1097/00002030-200009080-00020. [DOI] [PubMed] [Google Scholar]
  • 17.Riley ED, Safaeian M, Strathdee SA, Brooner RK, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse. 2002;37:1869–1886. doi: 10.1081/JA-120014088. [DOI] [PubMed] [Google Scholar]
  • 18.Downey L, Rosengren DB, Jackson TR, Donovan DM. Primary heroin users and drugfree treatment: an equation for success? Addict Behav. 2003;28:339–346. doi: 10.1016/S0306-4603(01)00295-7. [DOI] [PubMed] [Google Scholar]
  • 19.Millery M, Kleinman MM, Polisar NL, Millman RB, Scimeca M. Detoxification as a gateway to long-term treatment: assessing two interventions. J Subst Abuse Treat. 2002;23:183–190. doi: 10.1016/S0740-5472(02)00246-5. [DOI] [PubMed] [Google Scholar]
  • 20.Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press; 1991. [Google Scholar]
  • 21.Miller WR. Motivational interviewing. Research, practice, and puzzles. Addict Behav. 1996;21:835–842. doi: 10.1016/0306-4603(96)00044-5. [DOI] [PubMed] [Google Scholar]
  • 22.Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19:247–252. doi: 10.1016/S0740-5472(00)00104-5. [DOI] [PubMed] [Google Scholar]
  • 23.Booth RE, Kwiatkowski C, Iguchi MY, Pino F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep. 1998;113(Suppl. I):116–128. [PMC free article] [PubMed] [Google Scholar]
  • 24.Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatients substance abuse treatment organizations. Health Serv Res. 2003;38:887–903. doi: 10.1111/1475-6773.00151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Folstein MF, Folstein SE, McHugh PR, Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  • 26.First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis Disorders — Patient Edition (SCID-I/P, Version 2.0) New York, NY: New York State Psychiatric Institute; 1995. [Google Scholar]
  • 27.First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders — Patient Edition (SCID-II, Version 2.0) New York, NY: New York State Psychiatric Institute; 1995. [Google Scholar]
  • 28.Perry JC. Problems and considerations in the valid assessment of personality disorders. Am J Psychiatry. 1992;149:1645–1653. doi: 10.1176/ajp.149.12.1645. [DOI] [PubMed] [Google Scholar]
  • 29.Williams JBW, Gibbon M, First MB, et al. The structured clinical interview for DSM-III-R (SCID) II. Multisite test-rerest reliability. Arch Gen Psychiatry. 1992;49:630–636. doi: 10.1001/archpsyc.1992.01820080038006. [DOI] [PubMed] [Google Scholar]
  • 30.Kidorf M, Brooner RK, King VL, Chutuape M, Stitzer ML. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug Alcohol Depend. 1996;42:117–123. doi: 10.1016/0376-8716(96)01268-9. [DOI] [PubMed] [Google Scholar]
  • 31.Kidorf M, Brooner RK, King VL, Stoller KB, Wertz J. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. J Consult Clin Psychol. 1998;66:168–173. doi: 10.1037/0022-006X.66.1.168. [DOI] [PubMed] [Google Scholar]
  • 32.McLellan AT, Kushner J, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213. doi: 10.1016/0740-5472(92)90062-S. [DOI] [PubMed] [Google Scholar]
  • 33.Hendricks VM, Kaplan CD, Limbeek J, Geerlings P. The Addiction Severity Index: reliability and validity in a Dutch addict population. J Subst Abuse Treat. 1989;6:133–141. doi: 10.1016/0740-5472(89)90041-X. [DOI] [PubMed] [Google Scholar]
  • 34.Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the Addiction Severity Index. J Nerv Ment Dis. 1985;171:606–610. doi: 10.1097/00005053-198310000-00003. [DOI] [PubMed] [Google Scholar]
  • 35.McLellan AT, Luborsky L, Cacciola J, et al. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis. 1985;173:412–422. doi: 10.1097/00005053-198507000-00005. [DOI] [PubMed] [Google Scholar]
  • 36.Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T. Dynamic balanced randomization for clinical trials. Stat Med. 1993;12:2343–2350. doi: 10.1002/sim.4780122410. [DOI] [PubMed] [Google Scholar]
  • 37.Miller WR. Motivational Interviewing Skill Code: Coder’s Manual. Available at: http://casaa.unm.edu. Accessed June 30, 2005.
  • 38.Sia TL, Dansereau DF, Czuchry ML. Treatment readiness training and probationers evaluation of substance abuse treatment in a criminal justice setting. J Subst Abuse Treat. 2000;19:459–467. doi: 10.1016/S0740-5472(00)00139-2. [DOI] [PubMed] [Google Scholar]
  • 39.Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96:1725–1742. doi: 10.1046/j.1360-0443.2001.961217253.x. [DOI] [PubMed] [Google Scholar]
  • 40.Donovan DM, Rosengren DB, Downey L, Cox GB, Sloan KL. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction. 2001;96:1149–1160. doi: 10.1046/j.1360-0443.2001.96811498.x. [DOI] [PubMed] [Google Scholar]
  • 41.Jackson J, Rotkeiwicz LG, Quinones MA, Passannante MR. A coupon program—drug treatment and AIDS education. Int J Addict. 1989;24:1035–1051. doi: 10.3109/10826088909047327. [DOI] [PubMed] [Google Scholar]
  • 42.Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24:305–311. doi: 10.1016/S0740-5472(03)00038-2. [DOI] [PubMed] [Google Scholar]
  • 43.Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996;42:11–20. doi: 10.1016/0376-8716(96)01257-4. [DOI] [PubMed] [Google Scholar]
  • 44.Kwiatkowski CF, Booth RE, Lloyd LV. The effects of offering free treatment to streetrecruited opioid injectors. Addiction. 2000;95:697–704. doi: 10.1046/j.1360-0443.2000.9556975.x. [DOI] [PubMed] [Google Scholar]
  • 45.Sibthorpe B, Fleming D, Tesselaar H, Gould J, Nichols L. The response of injection drug users to free treatment on demand: implication for HIV control. Am J Drug Alcohol Abuse. 1996;22:203–213. doi: 10.3109/00952999609001654. [DOI] [PubMed] [Google Scholar]
  • 46.Sorensen JL, Costantini MF, Wall TL, Gibson DR. Coupons attract high-risk untreated heroin users into detoxification. Drug Alcohol Depend. 1993;31:247–252. doi: 10.1016/0376-8716(93)90007-D. [DOI] [PubMed] [Google Scholar]
  • 47.Wells EA, Fleming C, Calsyn DA, Jackson TR, Saxon AJ. Users of free treatment slots at a community-based methadone maintenance clinic. J Subst Abuse Treat. 1995;12:13–18. doi: 10.1016/0740-5472(94)00073-5. [DOI] [PubMed] [Google Scholar]
  • 48.Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994;36:129–138. doi: 10.1016/0376-8716(94)90095-7. [DOI] [PubMed] [Google Scholar]
  • 49.Project MATCH research Group Matching alcoholism treatment to client heterogeneity: project MATCH postreatment drinking outcomes. J Stud Alcohol. 1997;58:7–29. [PubMed] [Google Scholar]
  • 50.Brooner RK, Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Sci Pract Perspect. 2002;1:38–47. doi: 10.1151/spp021138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.McLellan AT, Arndt I, Metzger DA, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959. doi: 10.1001/jama.269.15.1953. [DOI] [PubMed] [Google Scholar]
  • 52.Simpson DD, Joe GW, Rowan-Szal G, Greener J. Client engagement and change during drug abuse treatment. J Subst Abuse. 1995;7:117–134. doi: 10.1016/0899-3289(95)90309-7. [DOI] [PubMed] [Google Scholar]
  • 53.Goldstein MF, Deren S, Kang SY, Jarlais DC, Magura S. Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry. Drug Alcohol Depend. 2002;66:181–187. doi: 10.1016/S0376-8716(01)00199-5. [DOI] [PubMed] [Google Scholar]
  • 54.Kidorf M, King VL, Brooner RK. Integrating psychosocial services with methadone treatment: behaviorally contingent pharmacotherapy. In: Strain EC, Stitzer ML, editors. Treatment of Opioid Dependence: Methadone and Alternative Medications. Baltimore, MD: Hopkins Press; 1999. pp. 166–195. [Google Scholar]
  • 55.Silverman K, Preston KL, Stitzer ML, Schuster CR. Efficacy and versatility of voucherbased reinforcement in drug abuse treatment. In: Higgins ST, Silverman K, editors. Motivating Behavior Change Among Illicit-Drug Abusers. Washington, D.C.: American Psychological Association; 1999. pp. 13–182. [Google Scholar]
  • 56.Kidorf M, Disney E, Kindbom K, Blucher J, Williams L, Depo J, Brooner RK. A motivational intervention for dramatically enhancing treatment enrollment of syringe exchange participants. Poster presented at: The 66th Annual College of Problems on Drug Dependence Scientific Meeting; June 12–17, 2004; San Juan, Puerto Rico.

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES